Literature DB >> 25746994

Novel Substrate Specificity and Temperature-Sensitive Activity of Mycosphaerella graminicola CYP51 Supported by the Native NADPH Cytochrome P450 Reductase.

Claire L Price1, Andrew G S Warrilow1, Josie E Parker1, Jonathan G L Mullins1, W David Nes2, Diane E Kelly3, Steven L Kelly3.   

Abstract

Mycosphaerella graminicola (Zymoseptoria tritici) is an ascomycete filamentous fungus that causes Septoria leaf blotch in wheat crops. In Europe the most widely used fungicides for this major disease are demethylation inhibitors (DMIs). Their target is the essential sterol 14α-demethylase (CYP51), which requires cytochrome P450 reductase (CPR) as its redox partner for functional activity. The M. graminicola CPR (MgCPR) is able to catalyze the sterol 14α-demethylation of eburicol and lanosterol when partnered with Candida albicans CYP51 (CaCYP51) and that of eburicol only with M. graminicola CYP51 (MgCYP51). The availability of the functional in vivo redox partner enabled the in vitro catalytic activity of MgCYP51 to be demonstrated for the first time. MgCYP51 50% inhibitory concentration (IC50) studies with epoxiconazole, tebuconazole, triadimenol, and prothioconazole-desthio confirmed that MgCYP51 bound these azole inhibitors tightly. The characterization of the MgCPR/MgCYP51 redox pairing has produced a functional method to evaluate the effects of agricultural azole fungicides, has demonstrated eburicol specificity in the activity observed, and supports the conclusion that prothioconazole is a profungicide.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25746994      PMCID: PMC4407231          DOI: 10.1128/AEM.03965-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  29 in total

1.  NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.

Authors:  G P Kurzban; J Howarth; G Palmer; H W Strobel
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

2.  Molecular diversity of sterol 14alpha-demethylase substrates in plants, fungi and humans.

Authors:  D C Lamb; D E Kelly; S L Kelly
Journal:  FEBS Lett       Date:  1998-03-27       Impact factor: 4.124

Review 3.  Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

Authors:  Florent Morio; Cedric Loge; Bernard Besse; Christophe Hennequin; Patrice Le Pape
Journal:  Diagn Microbiol Infect Dis       Date:  2010-04       Impact factor: 2.803

4.  Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).

Authors:  Andrew G S Warrilow; Claire M Martel; Josie E Parker; Nadja Melo; David C Lamb; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

5.  Candida albicans NADPH-P450 reductase: expression, purification, and characterization of recombinant protein.

Authors:  Hyoung-Goo Park; Young-Ran Lim; Chang-Yong Eun; Songhee Han; Jung-Soo Han; Kyoung Sang Cho; Young-Jin Chun; Donghak Kim
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

6.  Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH.

Authors:  D D Oprian; M J Coon
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

7.  Multiple mechanisms account for resistance to sterol 14α-demethylation inhibitors in field isolates of Mycosphaerella graminicola.

Authors:  Pierre Leroux; Anne-Sophie Walker
Journal:  Pest Manag Sci       Date:  2010-10-14       Impact factor: 4.845

8.  Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.

Authors:  Galina I Lepesheva; Robert D Ott; Tatiana Y Hargrove; Yuliya Y Kleshchenko; Inge Schuster; W David Nes; George C Hill; Fernando Villalta; Michael R Waterman
Journal:  Chem Biol       Date:  2007-11

9.  Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli.

Authors:  H J Barnes; M P Arlotto; M R Waterman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

10.  Mechanism of binding of prothioconazole to Mycosphaerella graminicola CYP51 differs from that of other azole antifungals.

Authors:  Josie E Parker; Andrew G S Warrilow; Hans J Cools; Claire M Martel; W David Nes; Bart A Fraaije; John A Lucas; Diane E Kelly; Steven L Kelly
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

View more
  5 in total

1.  The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.

Authors:  Andrew G S Warrilow; Josie E Parker; Claire L Price; Edward P Garvey; William J Hoekstra; Robert J Schotzinger; Nathan P Wiederhold; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 2.  Versatile biocatalysis of fungal cytochrome P450 monooxygenases.

Authors:  Pradeepraj Durairaj; Jae-Seoun Hur; Hyungdon Yun
Journal:  Microb Cell Fact       Date:  2016-07-18       Impact factor: 5.328

3.  Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.

Authors:  Joel D A Tyndall; Manya Sabherwal; Alia A Sagatova; Mikhail V Keniya; Jacopo Negroni; Rajni K Wilson; Matthew A Woods; Klaus Tietjen; Brian C Monk
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 4.  Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases.

Authors:  Brian C Monk; Mikhail V Keniya
Journal:  J Fungi (Basel)       Date:  2021-01-20

Review 5.  Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase Inhibitors.

Authors:  David J Leaver
Journal:  Molecules       Date:  2018-07-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.